Transarterial chemoembolization versus sorafenib in patients with hepatocellular carcinoma and extrahepatic disease.
Kirstein MM, Voigtländer T, Schweitzer N, Hinrichs JB, Marquardt J, Wörns MA, Kloeckner R, Fründt TW, Ittrich H, Wacker F, Rodt T, Manns MP, Wege H, Weinmann A, Vogel A.
Kirstein MM, et al. Among authors: schweitzer n.
United European Gastroenterol J. 2018 Mar;6(2):238-246. doi: 10.1177/2050640617716597. Epub 2017 Jun 20.
United European Gastroenterol J. 2018.
PMID: 29511553
Free PMC article.